Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
AIDS and Behavior
Published in: AIDS and Behavior 4/2001

01-12-2001

Injection Drug Users' Disclosure of HIV Seropositive Status to Network Members

Authors: Carl A. Latkin, Amy R. Knowlton, Valerie L. Forman, Donald R. Hoover, Jennifer R. Schroeder, Mark Hachey, David D. Celentano

Published in: AIDS and Behavior | Issue 4/2001

Login to get access
Metadata
Title
Injection Drug Users' Disclosure of HIV Seropositive Status to Network Members
Authors
Carl A. Latkin
Amy R. Knowlton
Valerie L. Forman
Donald R. Hoover
Jennifer R. Schroeder
Mark Hachey
David D. Celentano
Publication date
01-12-2001
Publisher
Kluwer Academic Publishers-Plenum Publishers
Published in
AIDS and Behavior / Issue 4/2001
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1023/A:1013149205122

Other articles of this Issue 4/2001

AIDS and Behavior 4/2001 Go to the issue

OriginalPaper

Impact of Needle Exchange Programs on Adolescent Perceptions About Illicit Drug Use

OriginalPaper

Social Factors Related to Antiretroviral Therapy Use in Injection Drug Users

OriginalPaper

Sexual Risk Behavior in Urban Populations of Northeastern Africa

OriginalPaper

The Theory of Planned Behavior and Safer Sex Behaviors of Gay Men

OriginalPaper

Employment, Social Support, and HIV Sexual-Risk Behavior in Puerto Rican Women

OriginalPaper

Prescription of and Adherence to Antiretroviral Therapy Among Women with AIDS
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits